New Delhi, January 21, 2026 IST: KRM Ayurveda Limited has opened its initial public offering for public subscription today, even as the company completed its anchor investor allocation a day earlier, raising funds at the upper end of the price band.
The SME IPO is open from January 21 to January 23, 2026, with the company set to list on January 29, 2026. The issue is priced in the range of ₹128 to ₹135 per share, with a total issue size of approximately ₹77.49 crore, entirely comprising a fresh issue.
Anchor Allocation Sets the Tone
Ahead of the public issue opening, KRM Ayurveda finalized the allotment of 15,42,000 equity shares to anchor investors at a price of ₹135 per share, aggregating to about ₹20.82 crore. The anchor allocation was approved by the board on January 20, 2026.Anchor Investors and Allocation Details
| Anchor Investor Name | Equity Shares Allotted | Share of Anchor Portion |
|---|---|---|
| Pine Oak Global Fund | 7,98,000 | 51.75% |
| Magnifica Global Opportunities VCC – MGO High Conviction Incorporated VCC Sub-Fund | 1,86,000 | 12.06% |
| Vikasa India EIF I Fund – Incube Global Opportunities | 1,86,000 | 12.06% |
| Cognizant Capital Dynamic Opportunities Fund | 1,86,000 | 12.06% |
| SageOne India Opportunity Trust | 1,86,000 | 12.06% |
| Total | 15,42,000 | 100.00% |
IPO Snapshot
| Particulars | Details |
|---|---|
| IPO Opening Date | January 21, 2026 |
| IPO Closing Date | January 23, 2026 |
| Price Band | ₹128 to ₹135 per share |
| Issue Size | ₹77.49 crore |
| Issue Type | 100% Fresh Issue |
| Listing Date | January 29, 2026 |
| Lot Size | 1,000 shares |
Use of Proceeds
The company plans to deploy the IPO proceeds across business expansion and balance sheet strengthening initiatives.| Purpose | Amount (₹ crore) | Share (%) |
|---|---|---|
| General corporate purposes | 26.46 | 34.15 |
| Working capital requirements | 18.00 | 23.23 |
| Capital expenditure for telemedicine facilities | 13.67 | 17.64 |
| Repayment or prepayment of loans | 12.50 | 16.13 |
| Human resources | 5.44 | 7.02 |
| CRM software and hardware infrastructure | 1.42 | 1.83 |
About the Company
Incorporated in September 2019 and converted into a public limited company in December 2024, KRM Ayurveda Limited operates in the AYUSH healthcare segment. The company integrates classical Ayurvedic practices with modern clinical protocols, offering treatments for chronic and lifestyle-related conditions including kidney disorders, liver ailments, diabetes, fatty liver, and arthritis.KRM Ayurveda runs a network of hospitals and clinics across multiple Indian cities and provides telemedicine services catering to both domestic and international patients. The company follows a patient-centric model combining in-person consultations, hospital-based care, and digital healthcare delivery. The equity shares are proposed to be listed on the SME platform, marking the company’s first entry into the capital markets.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.